Michal Woznica
Overview
Explore the profile of Michal Woznica including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
11
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Poniatowski L, Woznica M, Wojdasiewicz P, Mela-Kalicka A, Romanowska-Prochnicka K, Purrahman D, et al.
Cells
. 2024 Jan;
13(2).
PMID: 38247816
Glioblastoma multiforme (GBM) represents the most common and aggressive malignant form of brain tumour in adults and is characterized by an extremely poor prognosis with dismal survival rates. Currently, expanding...
2.
Woznica M, Kaczor S, Poniatowski L, Razniak M, Zabek M
J Clin Med
. 2023 Nov;
12(21).
PMID: 37959402
The purpose of this case report is to describe the case of a patient with ankylosing spinal hyperostosis (ASH) and lumbar spine fracture complicated by ureteral injury mimicking spondylodiscitis with...
3.
Toczylowska B, Woznica M, Zieminska E, Krolicki L
Int J Mol Sci
. 2023 Jul;
24(13).
PMID: 37445750
Background: Degeneration of the intervertebral disc (IVD) is caused by disturbances in metabolic processes, which lead to structural disorders. The aim of this report is to analyze metabolic disorders in...
4.
Hermann B, Woznica M, Kloc W, Borkowski P, Libionka W, Izycka-Swieszewska E
Folia Neuropathol
. 2017 Oct;
55(3):227-234.
PMID: 28984116
We present a case of a rare neoplasm in a 77-year-old woman with previous oncological history, who developed a rapid onset of cerebellar symptoms. The neuroimaging detected a posterior fossa...
5.
Woznica M, Rosahl S, Berlis A, Weyerbrock A
Acta Neurochir (Wien)
. 2009 Oct;
152(3):417-22.
PMID: 19806303
Purpose: Between 15 and 30 % of patients with subarachnoid hemorrhage (SAH) have no bleeding source and usually have a benign clinical course and outcome. The objectives of this study...